Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Human papillomavirus vaccine recombinant pentavalent - Merck

Next Previous
Drug Profile

Human papillomavirus vaccine recombinant pentavalent - Merck

Alternative Names: 5-valent HPV L1 VLP vaccine - Merck; Human papillomavirus (types 31, 33, 45, 52, 58) L1 virus-like particle vaccine - Merck; Pentavalent HPV VLP vaccine - Merck; Prophylactic 5-valent HPV (Types 31, 33, 45, 52, 58) L1 virus-like particle vaccine - Merck; V-504

Latest Information Update: 25 Feb 2014

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Merck & Co
  • Class Cancer vaccines; Papillomavirus vaccines; Virus-like particle vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Cervical cancer; Human papillomavirus infections

Most Recent Events

  • 01 Oct 2007 Phase-II clinical trials in Cervical cancer (prevention) in USA, Sweden and Austria (IM)
  • 01 Oct 2007 Phase-II clinical trials in Human papillomavirus infections (prevention) in USA, Sweden and Austria (IM)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top